United Kingdom (UK) Biosimilar Monoclonal Antibody Market (2025-2031) | Segmentation, Forecast, Value, Trends, Analysis, Industry, Outlook, Share, Companies, Size & Revenue, Growth, Competitive Landscape

Market Forecast By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End User (Hospitals, Cancer treatment centers, Others) And Competitive Landscape
Product Code: ETC9939247 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Biosimilar Monoclonal Antibody Market Outlook
  • Market Size of United Kingdom (UK) Biosimilar Monoclonal Antibody Market, 2024
  • Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Market Trend Evolution
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Market Drivers and Challenges
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Price Trends
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Porter's Five Forces
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Adalimumab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Bevacizumab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Infliximab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Rituximab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Trastuzumab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Oncology for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Autoimmune diseases for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Cancer treatment centers for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By End User
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Top Companies Market Share
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Company Profiles
  • United Kingdom (UK) Biosimilar Monoclonal Antibody Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?
6Wresearch actively monitors the United Kingdom (UK) Biosimilar Monoclonal Antibody Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Biosimilar Monoclonal Antibody Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market - Industry Life Cycle

3.4 United Kingdom (UK) Biosimilar Monoclonal Antibody Market - Porter's Five Forces

3.5 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in the UK driving the demand for biosimilar monoclonal antibodies.

4.2.2 Cost-effectiveness and affordability compared to originator biologics.

4.2.3 Supportive government policies and initiatives promoting the adoption of biosimilars.

4.3 Market Restraints

4.3.1 Limited awareness and education among healthcare professionals and patients about biosimilar monoclonal antibodies.

4.3.2 Stringent regulatory requirements for approval and market entry.

4.3.3 Competition from established originator biologics and upcoming biosimilar products.

5 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Trends

6 United Kingdom (UK) Biosimilar Monoclonal Antibody Market, By Types

6.1 United Kingdom (UK) Biosimilar Monoclonal Antibody Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Adalimumab, 2021- 2031F

6.1.4 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Bevacizumab, 2021- 2031F

6.1.5 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Infliximab, 2021- 2031F

6.1.6 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Rituximab, 2021- 2031F

6.1.7 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Trastuzumab, 2021- 2031F

6.1.8 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Autoimmune diseases, 2021- 2031F

6.2.4 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market, By End User

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Cancer treatment centers, 2021- 2031F

6.3.4 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Export to Major Countries

7.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Imports from Major Countries

8 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Key Performance Indicators

8.1 Physician adoption rate of biosimilar monoclonal antibodies.

8.2 Patient acceptance and compliance with biosimilar treatments.

8.3 Number of government tenders or contracts awarded for biosimilar monoclonal antibodies.

8.4 Rate of reimbursement coverage for biosimilar monoclonal antibodies.

8.5 Research and development investments in biosimilar monoclonal antibody development.

9 United Kingdom (UK) Biosimilar Monoclonal Antibody Market - Opportunity Assessment

9.1 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Opportunity Assessment, By End User, 2021 & 2031F

10 United Kingdom (UK) Biosimilar Monoclonal Antibody Market - Competitive Landscape

10.1 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Biosimilar Monoclonal Antibody Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Thought Leadership and Analyst Meet

Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Visitors exploring electric vehicle technologies and innovations at EV India Expo 2021
Thought Leadership and Analyst Meet
View All

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Stationery & Paper Expo Saudi Arabia 2026

Stationery & Paper Expo Saudi Arabia 2026

Kids & Toys Expo Saudi Arabia 2026

Kids & Toys Expo Saudi Arabia 2026

Gifts & Homeware Expo Saudi Arabia 2026

Gifts & Homeware Expo Saudi Arabia 2026

Smart Home Expo 2026

Smart Home Expo 2026

Industrial Facilities Management Expo 2025

Industrial Facilities Management Expo 2025

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Thought Leadership and Analyst Meet
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
Agriculture
©2025 6Wresearch, All Right Reserved